Longeveron LLC (LGVN)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | BLASS, DEVIN | CTO & SVP of CMC | Class A Common Stock | Acquisition | 286,000 | 0 |
| Aug 19, 2026 | ASCHEIM, DEBORAH | Director | Class A Common Stock | Acquisition | 36,000 | 0 |
| Aug 19, 2026 | UNGARO, URSULA | Director | Class A Common Stock | Acquisition | 36,000 | 0 |
| Aug 19, 2026 | HAJJAR, ROGER JOSEPH | Director | Class A Common Stock | Acquisition | 36,000 | 0 |
| Aug 19, 2026 | PALETTA, GEORGE A. JR. | Director | Class A Common Stock | Acquisition | 36,000 | 0 |
| Aug 19, 2026 | SOFFER, ROCK | Director | Class A Common Stock | Acquisition | 36,000 | 0 |
| Aug 19, 2026 | DESAI, ARJUN JJ | Director | Class A Common Stock | Acquisition | 36,000 | 0 |
| Aug 19, 2026 | LEHR, PAUL T | General Counsel, Secretary | Class A Common Stock | Acquisition | 286,000 | 0 |
| Aug 19, 2026 | CANN, LEAH RUSH | Director | Class A Common Stock | Acquisition | 36,000 | 0 |
| Aug 19, 2026 | HARE, JOSHUA | Director, Chief Scientific Officer, 10% Owner | Class A Common Stock | Acquisition | 286,000 | 0 |
| Aug 19, 2026 | AGAFONOVA, NATALIYA | Chief Medical Officer | Class A Common Stock | Acquisition | 286,000 | 0 |
| Aug 17, 2026 | JHAVERI, NIRAV S. | Chief Financial Officer | Class A Common Stock | Acquisition | 300,000 | 0 |
| Jul 6, 2026 | HARE, JOSHUA | Director, Chief Scientific Officer, 10% Owner | Stock Option (right to buy) | Acquisition | 400,000 | 0 |
| Jul 6, 2026 | HARE, JOSHUA | Director, Chief Scientific Officer, 10% Owner | Class B Common Stock | Acquisition | 600,000 | 0 |
| Jul 1, 2026 | LEHR, PAUL T | General Counsel, Secretary | Class A Common Stock | Disposal | 13,143 | 0.729 |
| Jul 1, 2026 | WILLARD, STEPHEN H | Chief Executive Officer | Class A Common Stock | Disposal | 18,046 | 0.729 |
| Jul 1, 2026 | LOCKLEAR, LISA | Chief Financial Officer | Class A Common Stock | Disposal | 22,505 | 0.729 |
| Jul 1, 2026 | BLASS, DEVIN | CTO & SVP of CMC | Class A Common Stock | Disposal | 15,808 | 0.729 |
| Jul 1, 2026 | AGAFONOVA, NATALIYA | Chief Medical Officer | Class A Common Stock | Disposal | 22,505 | 0.729 |
| May 1, 2026 | BLASS, DEVIN | CTO & SVP of CMC | Class A Common Stock | Acquisition | 250,000 | 0 |
| May 1, 2026 | AGAFONOVA, NATALIYA | Chief Medical Officer | Class A Common Stock | Acquisition | 250,000 | 0 |
| May 1, 2026 | LEHR, PAUL T | General Counsel, Secretary | Class A Common Stock | Acquisition | 250,000 | 0 |
| May 1, 2026 | WILLARD, STEPHEN H | Chief Executive Officer | Class A Common Stock | Acquisition | 500,000 | 0 |
| May 1, 2026 | LOCKLEAR, LISA | Chief Financial Officer | Class A Common Stock | Acquisition | 250,000 | 0 |
| Apr 1, 2026 | LEHR, PAUL T | General Counsel, Secretary | Class A Common Stock | Disposal | 5,611 | 1.12 |
| Apr 1, 2026 | BLASS, DEVIN | CTO & SVP of CMC | Class A Common Stock | Disposal | 8,633 | 1.12 |
| Apr 1, 2026 | AGAFONOVA, NATALIYA | Chief Medical Officer | Class A Common Stock | Disposal | 13,145 | 1.12 |
| Apr 1, 2026 | LOCKLEAR, LISA | Chief Financial Officer | Class A Common Stock | Disposal | 13,145 | 1.12 |
| Apr 1, 2026 | WILLARD, STEPHEN H | Chief Executive Officer | Class A Common Stock | Disposal | 4,740 | 1.12 |
| Mar 2, 2026 | WILLARD, STEPHEN H | Chief Executive Officer | Stock Option (right to buy) | Acquisition | 200,000 | 0 |
| Mar 2, 2026 | WILLARD, STEPHEN H | Chief Executive Officer | Class A Common Stock | Acquisition | 200,000 | 0 |
| Mar 2, 2026 | WILLARD, STEPHEN H | Chief Executive Officer | Class A Common Stock | Disposal | 105,533 | 0.545 |
| Jan 2, 2026 | POWELL, JAMES NATHANIEL | Chief Executive Officer | Class A Common Stock | Disposal | 2,464 | 0.593 |
| Jan 2, 2026 | BLASS, DEVIN | CTO & SVP of CMC | Class A Common Stock | Disposal | 10,700 | 0.593 |
| Jan 2, 2026 | LOCKLEAR, LISA | Chief Financial Officer | Class A Common Stock | Disposal | 10,250 | 0.593 |
| Jan 2, 2026 | AGAFONOVA, NATALIYA | Chief Medical Officer | Class A Common Stock | Disposal | 10,250 | 0.593 |
| Jan 2, 2026 | LEHR, PAUL T | General Counsel, Secretary | Class A Common Stock | Disposal | 6,952 | 0.593 |
| Oct 1, 2025 | POWELL, JAMES NATHANIEL | Chief Executive Officer | Class A Common Stock | Disposal | 2,389 | 0.742 |
| Oct 1, 2025 | LOCKLEAR, LISA | Chief Financial Officer | Class A Common Stock | Disposal | 11,883 | 0.742 |
| Oct 1, 2025 | AGAFONOVA, NATALIYA | Chief Medical Officer | Class A Common Stock | Disposal | 11,883 | 0.742 |
| Oct 1, 2025 | BLASS, DEVIN | CTO & SVP of CMC | Class A Common Stock | Disposal | 7,609 | 0.742 |
| Oct 1, 2025 | PALETTA, GEORGE A. JR. | Director | Class A Common Stock | Acquisition | 34,000 | 0 |
| Oct 1, 2025 | LEHR, PAUL T | General Counsel, Secretary | Class A Common Stock | Disposal | 4,944 | 0.742 |